KAITEKI Value for Tomorrow

Next-generation Healthcare

How LSII Will Contribute to the Future of Society

Some patients are suffering from illnesses that are not adequately treated by current conventional treatments. LSII is creating a future where Muse cells (Multilineage-differentiating stress enduring cells) can be used to treat unmet medical needs*1 and improve the quality of life, that is, an individual’s perception of their position in life in the context of the culture and value systems in which they live, in relation to their goals.

*1 Unmet medical needs: Conditions for which there are currently no satisfactory diagnosis, prevention, or treatment methods available

Regenerative Medicine: The Road to Practical Application

Muse cells IMAGE

Provided by Professor Mari Dezawa (Stem Cell Biology and Histology, Tohoku University School of Medicine)

Since 2015, LSII has been researching and developing Muse cell-based products with high potential for clinical safety and efficacy, which may open the door to ”Next-Generation Medical Care.”

Muse cells are endogenous non-tumorigenic reparative pluripotent stem cells that naturally exist in the body. These properties have earned Muse cells a reputation as promising pluripotent stem cells with potential applications in regenerative medicine for a wide range of conditions.

Because Muse cells are alive, they cannot be sterilized by heating or other conventional methods during the formulation process. This is why each step in the process, from the raw materials and cell banks to cultivation and formulation, must be clearly managed. Quality control test methods are essential to develop and manage manufacturing processes that reliably produce high-potency Muse cell products with assured quality.

LSII Initiatives

Experiment IMAGE

LSII has been conducting clinical trials to create CL2020, a Muse cell-based regenerative medicine product. We are striving to initiate clinical trials as soon as possible for diseases based on sufficient safety and efficacy profiles in animal testing within the scope of Life Cycle Management. LSII has taken necessary steps towards the practical application of Muse cells, with the goal of a future society in which everyone can hope to overcome disease and injury.

Alliances with Group Corporations and Research Institutes

LSII promotes its Next-generation Healthcare business through collaborations within the MCHC Group and open innovation with research institutes.

Alliances with Group Corporations and Research Institutes IMAGE Alliances with Group Corporations and Research Institutes IMAGE
Research Center IMAGE

Research Center

The LSII Muse cell processing center is located at the Life Innovation Center in the Tonomachi district of Kawasaki City, southwest of Haneda Airport on the opposite shore of the Tama River, where the most advanced life science industry companies and research institutes are concentrated.

Tonomachi CPC (Cell Processing Center)
Life Innovation Center, 3-25-22 Tonomachi, Kawasaki-ku
Kawasaki, Kanagawa 210-0821, Japan

PAGE TOP